Abstract
Atrial fibrillation (AF) and heart failure (HF) are diseases affecting approximately 60 million people worldwide each. AF patients suffer from an irregular heartbeat and HF patients experience a loss of pump function. Pharmacological treatments of AF, HF, and related heart muscle diseases (cardiomyopathies) focus predominantly on symptom relief and a
... read more